GSA Capital Partners »

Aerovate Therapeutics shares owned by GSA Capital Partners

Quarter-by-quarter ownership of Aerovate Therapeutics (AVTE) shares owned by GSA Capital Partners from 13F filings

Historical chart of GSA Capital Partners investment in Aerovate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aerovate Therapeutics held by GSA Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aerovate Therapeutics by GSA Capital Partners

Quarter filed Position value Share count Share price at filing
2024-09-30 $865k 414k 2.09
2024-06-30 $210k 127k 1.66

More positions owned by GSA Capital Partners

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Global Ship Lease Com Cl A (GSL)
Staar Surgical Com Par $0.01 (STAA)
Progressive Corporation (PGR)
Accenture Plc Ireland Shs Class A (ACN)
Star Bulk Carriers Corp. Shs Par (SBLK)
Teck Resources CL B (TECK)
Vital Farms (VITL)
TJX Companies (TJX)
Fresh Del Monte Produce Ord (FDP)
Magnite Ord (MGNI)
Comcast Corp Cl A (CMCSA)

View all positions for GSA Capital Partners

Top funds holding Aerovate Therapeutics

RA Capital Management
Sofinnova Ventures
TCG Crossover Management
Atlas Venture Life Science Advisors
Deerfield Management Company
Vanguard Group
BlackRock
BlackRock
Baker Bros. Advisors
Affinity Asset Advisors
Octagon Capital Advisors
Opaleye Management
GSA Capital Partners
Ikarian Capital
Acadian Asset Management

View all funds holding Aerovate Therapeutics